Global Oxygen Therapy Device Market

Global Oxygen Therapy Device Market Size Insights Forecasts to 2035

• The Global Oxygen Therapy Device Market Size Was Estimated at USD 2421.75 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.29 % from 2025 to 2035
• The Worldwide Oxygen Therapy Device Market Size is Expected to Reach USD 4737.44 Million by 2035
• North America is expected to grow the fastest during the forecast period.

According to a research report published by Decisions Advisors and Consulting, The Global Oxygen Therapy Device Market Size Was Worth Around USD 2421.75 Million In 2024 And Is Predicted To Grow To Around USD 4737.44 Million By 2035 With A Compound Annual Growth Rate (CAGR) Of 6.29 % From 2025 To 2035. The oxygen therapy device market is probably being deeply influenced by the growing exodus to home healthcare. Consumers will probably choose equipment that makes treatment at home possible, which will incite a trend in the infusion of home oxygen therapy solution offerings. More stringent guidelines and standards may lead to a situation where manufacturers would focus on safety and efficacy above all, which, thus, may lead to products of higher quality being available to consumers.

 

Market Overview

The oxygen therapy device market is the worldwide industry that manufactures, makes, and sells medical equipment providing additional oxygen to people with respiratory disorders, hypoxemia, or other conditions necessitating oxygen support. Such devices provide sufficient oxygenation during both acute and chronic care scenarios. They have become a significant area of focus as the prevalence of respiratory diseases continues to rise globally. Moreover, oxygen therapy equipment is crucial in delivering supplemental oxygen to patients with pulmonary disorders such as COPD and asthma.

 

According to the World Health Organisation (WHO) report on asthma, approximately 262 million people had asthma, and 461, 000 deaths were attributed to asthma globally. Furthermore, COPD, or chronic obstructive pulmonary disease, is the third leading cause of death in the world, responsible for 3.23 million deaths globally. Exposure to environmental tobacco smoke, indoor air pollution, and occupational dust, fumes, and chemicals are major risk factors for COPD. Based on the data available in 2021 from the WHO, Pneumonia is responsible for 800,000 deaths annually. It has been estimated that 2040% of these deaths can be avoided if oxygen therapy devices, such as oxygen concentrators, are made available to the patients who require supplemental oxygen for respiratory disorders. Hence, the global oxygen therapy devices are further highlighted. Besides, the oxygen concentrators segment is making significant advancements, accelerated by the introduction of innovative technological breakthroughs.

 

Report Coverage

This research report categorises the oxygen therapy device market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the oxygen therapy device market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the oxygen therapy device market.     

 

Driving Factors  

The oxygen therapy device market today is witnessing significant changes, mainly pushed by technology developments and a growing understanding of respiratory health. The increasing number of people suffering from chronic respiratory diseases and the ageing of the population seem to be the main factors driving the demand for oxygen therapy solutions. Besides that, the coupling of telehealth services with oxygen therapy can improve patient monitoring and, therefore, adherence to treatment protocols, which might result in better health outcomes. At the same time, regulatory authorities are putting more emphasis on the safety and effectiveness of oxygen therapy devices. Such regulatory pressure could create a more competitive environment and, hence, push manufacturers to commit to research and development. Looking at market developments, the focus on personalised medicine and tailored therapies is likely to become a significant factor in determining the offerings of the future. The oxygen therapy device market has a bright future with its growth being fuelled by technological innovations and a stronger emphasis on patient, centric care.

 

Restraining Factors  

However, one of the major factors restricting the market is the high price of technologically advanced equipment, which makes it difficult for poor communities to have access to the devices. Moreover, stringent regulatory approvals and reimbursement issues further delay the adoption of the devices in different areas. Lastly, the risk of device-related problems and the lack of knowledge among patients about oxygen therapy devices are also reasons why oxygen therapy devices are not widely used.

 

Market Segmentation    

The oxygen therapy device market share is classified into type, and application.     

 

• The oxygen concentrators segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.        

Based on the type, the oxygen therapy device market is differentiated into oxygen concentrators, liquid oxygen systems, oxygen cylinders, portable oxygen devices, and oxygen accessories. Among these, the oxygen concentrators segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. This segment growth is driven by their mobility and portability that extremely suitable for the patients who are actively moving around. The power source for these devices is batteries, which is the main benefit that users can be free from the dependence on electrical outlets to be able to move around.

 

• The chronic obstructive pulmonary disease segment accounted for the highest revenue share in 2024 and is projected to grow at a remarkable CAGR over the forecast period.      

Based on the application, the oxygen therapy device market is segmented into chronic obstructive pulmonary disease, asthma, respiratory distress syndrome, sleep apnea, and cystic fibrosis. Among these, the chronic obstructive pulmonary disease segment accounted for the highest revenue share in 2024 and is projected to grow at a remarkable CAGR over the forecast period. The chronic obstructive pulmonary disease (COPD) continues to be a major contributor to the demand for oxygen therapy devices. This is affected by this disease and the increasing number of patients diagnosed each year. Moreover, this disease is better managed with continuous oxygen therapy, which helps to maintain a secure place for it in the market.

Regional Segment Analysis of the Oxygen Therapy Device Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

Asia Pacific is anticipated to hold the largest share of the oxygen therapy device market over the predicted timeframe.     

Asia Pacific is anticipated to hold the largest share of the oxygen therapy device market over the predicted timeframe. The Asia-Pacific region is an oxygen therapy device market very hot in the near future, where the size of the market is expected to reach USD 396.91 million by 2025. There are a few factors that are leading to the rising demand in the oxygen therapy device market, such as increasing pollution levels, the occurrence of chronic respiratory diseases, and an ageing population. Besides, the market is expected to grow further with healthcare infrastructure improvements due to government initiatives.

 

Japan, Australia, and China are market front-runners with investors such as Nidek Medical and ResMed making notable investments.

 

North America is projected to grow at a rapid CAGR in the oxygen therapy device market during the forecast period. North America is expected to stay the leader in the oxygen therapy device market due to the ageing population, rising prevalence of respiratory diseases, and technological advancements, which have been the primary factors driving the region's growth. Further innovations and market expansion are ensured through the regulatory support from agencies such as the FDA; thus, patients have access to the latest therapeutic options.

 

The United States remains the largest market and home to the major players such as Invacare, AirSep Corporation, and DeVilbiss Healthcare. The competition in the market is mostly based on continuous product development and strategic partnerships. Companies are now concentrating on improving the user experience and incorporating smart technologies in their products; thus, it is expected that the market will further grow in the next few years.

 

Competitive Analysis:   

The report offers the appropriate analysis of the key organizations/companies involved within the oxygen therapy device market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.  

 

List of Key Companies

• AirSep Corporation
• Breas Medical
• DeVilbiss Healthcare
• Fisher & Paykel Healthcare
• Invacare
• Nidek Medical
• OxySure Systems
• Philips
• ResMed
• Others  

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

 

Recent Development

 

• In June 2025, Inogen launched the Voxi 5 Stationary Oxygen Concentrator, positioning it as a durable, affordable solution for long-term oxygen therapy in home care settings. It delivers continuous flow oxygen (1–5 LPM), features a compact design with caster wheels, and was co-developed with Yuwell Medical to improve accessibility for patients in the U.S.

 

Market Segment  

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the oxygen therapy device market based on the below-mentioned segments: 

  

Global Oxygen Therapy Device Market, By Type

• Oxygen Concentrators
• Liquid Oxygen Systems
• Oxygen Cylinders
• Portable Oxygen Devices
• Oxygen Accessories

 

Global Oxygen Therapy Device Market, By Application

• Chronic Obstructive Pulmonary Disease
• Asthma
• Respiratory Distress Syndrome
• Sleep Apnea
• Cystic Fibrosis

 

Global Oxygen Therapy Device Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

 

Frequently Asked Questions (FAQ)

1. What is the expected market size growth?

The market was valued at USD 2,421.75 million in 2024 and is projected to reach USD 4,737.44 million by 2035, growing at a CAGR of 6.29% from 2025 to 2035.

 

2. Which region holds the largest market share?

Asia-Pacific is expected to hold the largest share, driven by rising pollution, chronic respiratory diseases, ageing populations, and government healthcare initiatives in countries like China, Japan, and India.

 

3. Which product type leads the market?

Oxygen concentrators dominated in 2024 and are projected to grow at a substantial CAGR, thanks to their portability, battery power, and suitability for mobile patients.

 

4. Which application segment has the highest revenue?

Chronic Obstructive Pulmonary Disease (COPD) accounted for the highest share in 2024 and is expected to grow at a remarkable CAGR due to increasing diagnoses and the need for continuous oxygen support.

 

5. What are the main growth drivers?

Key factors include rising chronic respiratory diseases (e.g., COPD, asthma), ageing populations, home healthcare trends, technological innovations, and telehealth integration.

 

6. What challenges restrain market growth?

High costs of advanced devices, stringent regulations, reimbursement issues, device-related risks, and limited patient awareness hinder wider adoption, especially in low-income areas.

 

7. Which region is growing the fastest?

North America is projected to grow at the fastest CAGR, fueled by an ageing population, high respiratory disease prevalence, FDA support, and innovations from U.S. companies like Invacare and Philips.

 

8. Who are the key market players?

Leading companies include AirSep Corporation, Breas Medical, DeVilbiss Healthcare, Fisher & Paykel Healthcare, Invacare, Nidek Medical, OxySure Systems, Philips, and ResMed.